loader
Please Wait
Applying Filters...
menu
    • menu

    Europe: Anvisa approves influenza vaccine for the elderly - Sanofi

    MenuSanofi

    Uploaded: 2021
    News
    Tolebrutinib phase 3 data in NEJM show benefit in MS disability

    08 Apr 2025

    // PRESS RELEASE

    Rilzabrutinib granted orphan drug designation in US for 2 diseases

    04 Apr 2025

    // PRESS RELEASE

    Sanofi pays Nurix $15M upfront for autoimmune degrader

    03 Apr 2025

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Sanofi 250

    Contact Supplier

    Website

    BIO International Convention

    Exhibiting

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/m_Qi26UsERU
    Xls

    CATEGORY PAGE
    Menu

    Sanofi

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC107029